Literature DB >> 7740998

Animal models of hepatic encephalopathy and hyperammonemia.

K D Mullen1, S Birgisson, R C Gacad, H Conjeevaram.   

Abstract

Animal models of chronic liver disease with hyperammonemia are currently available to investigators. Two in particular have been utilized extensively. Carbon tetrachloride induced (CCl4) cirrhosis in the rat and portacaval shunt in the same species and other animals particularly the dog. In regards to hepatic encephalopathy, however, the CCl4 cirrhosis rat model seems to display few behavioral changes unless very advanced decompensated cirrhosis is produced. Further work should be done on this model to verify the development of encephalopathy and to improve reproducibility. The portacaval shunt rat on the other hand clearly has a consistent albeit subtle set of behavioral changes. Recent improvements in detecting these changes and more importantly showing reversal or improvement by neomycin or a low protein diet are a major advance. Hopefully, more laboratories will be able to reproduce this reversible change in behavior. Experiences gained from 7 years of using the portacaval shunt rat and other models of liver disease are described.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7740998     DOI: 10.1007/978-1-4615-1989-8_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Hyperammonemia and chronic hepatic encephalopathy: an in vivo PMRS study of the rat brain.

Authors:  D Astore; C A Boicelli
Journal:  MAGMA       Date:  2000-07       Impact factor: 2.310

2.  Efficacy of L-carnitine in reducing hyperammonaemia and improving neuropsychological test performance in patients with hepatic cirrhosis : results of a randomised trial.

Authors:  Angelo Cecere; Francesco Ciaramella; Luciano Tancredi; Ciro Romano; Adriano Gattoni
Journal:  Clin Drug Investig       Date:  2002-11       Impact factor: 2.859

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.